Argan (AGX) Drops as Falling Backlog Overshadows Record Revenue

Argan (AGX) fell 15.21% over the past month, extending its 52-week loss to 18.25%, despite reporting record revenue of $384 million. The decline was attributed to a falling project backlog and broader market selloffs. Buffalo Small Cap Growth Fund noted Argan as a performance detractor.

Original reporting
Published Nov 18, 2026, 3:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 3:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Argan (AGX) Drops as Falling Backlog Overshadows Record Revenue — source image
Decision brief

The 30-second read

$AGXBearishMed
01

Why it matters

It frames AGX’s valuation risk around backlog falling from $2.9B to $2.5B, even as revenue rose 62% year over year to a record $384M.

02

Market read

Traders may reassess AGX’s near-term award pipeline and backlog conversion, which the article identifies as the core reason for the stock’s decline.

03

What to watch

The article attributes weakness partly to a broader AI-power infrastructure selloff, so some of the move may be sector beta rather than AGX-specific fundamentals.

Relevance 6/10Novelty 5/10Timing: as of the Nov. 17 close, with the backlog narrative driving the recent selloff

Background

The piece is based on a Buffalo Small Cap Growth Fund Q3 2026 investor letter discussing Argan’s performance drivers.

Company-level read

Ticker impact

$AGXBearishHigh confidence
Context

Argan’s record Q3 revenue and net income were offset by a backlog drop to $2.5B from $2.9B, driving a sharp selloff.

Expected impact

Likely continued downside pressure or high volatility as the market reprices the backlog-to-awards outlook.

Evidence & confidence

The article directly links the stock decline to falling backlog and investor concerns about the pace of new awards, which is a primary driver for valuation in EPC/power infrastructure services.

Market effects

Highlights how power-generation and renewable-energy EPC names can trade on backlog momentum, not just revenue prints.

No specific regional spillover beyond US small-cap growth sentiment.

Limited, as the catalyst is company-specific backlog and AI-power infrastructure demand expectations.

Counterpoint

Record revenue and net income suggest operational strength; backlog decline may reflect timing of awards rather than a structural demand collapse.

Key entities

  • Argan, Inc.

    Engineering, procurement, construction, and technical services provider for power generation and renewable energy markets, including Gemma Power Systems.

  • Buffalo Small Cap Growth Fund

    Actively managed mutual fund whose investor letter cites AGX as a performance detractor.

Related articles

$AGXMed

Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)

Silver X Mining Corp. (AGX) filed an updated NI 43-101 technical report for its Nueva Recuperada project in Peru, showing increased mineral resources. Measured and Indicated resources total 10.4 Mt with 67.3 Moz AgEq, up 107% from the previous estimate. Inferred resources total 21.6 Mt with 184.3 Moz AgEq. The report includes revisions from the September 22, 2026 news release, with no change in tonnage or classification. The company plans to expand its mining operations and plant capacity.

$AGXMedAI 8/10

Argan’s (AGX) Power Boom Comes With A Margin Catch

Argan (AGX) reported record Q2 revenue of $384.0M (+61.5% YoY) and net income of $53.3M, driven by its Power segment. Gross margin slipped to 19.3%, and backlog decreased to $2.5B. The company is debt-free with $1.03B in cash, returning $51.7M to shareholders. Management expects new projects but faces regulatory challenges and margin compression.

$AGXMed

Argan (AGX) Q2 2027 Earnings Call Transcript

Argan (AGX) reported Q2 2027 revenue of $384.0M, up 61.5%, with net income of $53.3M ($3.76 per diluted share). Power segment revenue grew 53% YoY to $301M, while Industrial segment revenue rose 111% to $76M. Consolidated backlog decreased to $2.5B. The company plans to complete a new fabrication facility in North Carolina by Q3 2027.